| Evaluating Progression-Free Survival as a Surrogate Outcome for Health-Related Quality of Life in Oncology: A Systematic Review and Quantitative Analysis B Kovic, X Jin, SA Kennedy, M Hylands, M Pędziwiatr, A Kuriyama, ... JAMA Internal Medicine, 2018 | 108 | 2018 |
| Google Search as an Additional Source in Systematic Reviews J Piasecki, M Waligora, V Dranseika Science and Engineering Ethics, 2017 | 87 | 2017 |
| Research in disaster settings: a systematic qualitative review of ethical guidelines S Mezinska, P Kakuk, G Mijaljica, M Waligóra, D O'Mathúna BMC Medical Ethics 17 (62), 1-11, 2016 | 76 | 2016 |
| A systematic review on how patients value chronic obstructive pulmonary disease outcomes Y Zhang, RL Morgan, P Alonso-Coello, W Wiercioch, MM Bała, ... European Respiratory Journal, 2018 | 69* | 2018 |
| Child’s assent in research: Age threshold or personalisation? M Waligora, V Dranseika, J Piasecki BMC medical ethics 15, 1-7, 2014 | 60 | 2014 |
| Umbrella and basket trials in oncology: ethical challenges K Strzebonska, M Waligora BMC Medical Ethics 20, 2019 | 43 | 2019 |
| Risk and surrogate benefit for pediatric phase I trials in oncology: a systematic review with meta-analysis M Waligora, MM Bala, M Koperny, MT Wasylewski, K Strzebonska, ... PLoS medicine 15 (2), e1002505, 2018 | 40 | 2018 |
| Relevant Information and Informed Consent in Research: In Defense of the Subjective Standard of Disclosure V Dranseika, J Piasecki, M Waligora Science and Engineering Ethics, 1-11, 2016 | 38 | 2016 |
| Publication Ethics in Biomedical Journals from Countries in Central and Eastern Europe M Broga, G Mijaljica, M Waligora, A Keis, A Marusic Science and Engineering Ethics, Springer, 2013 | 31 | 2013 |
| What Do Ethical Guidelines for Epidemiology Say About an Ethics Review? A Qualitative Systematic Review J Piasecki, M Waligora, D Vilius Science and Engineering Ethics 23 (3), 743–768, 2017 | 21 | 2017 |
| Wstęp do fenomenologii M Waligóra Towarzystwo Autorów i Wydawców Prac Naukowych UNIVERSITAS, 2013 | 18 | 2013 |
| Forensic uses of research biobanks: should donors be informed? V Dranseika, J Piasecki, M Waligora Medicine, Health Care and Philosophy, 1-6, 2015 | 17 | 2015 |
| Non-beneficial pediatric research: individual and social interests J Piasecki, M Waligora, V Dranseika Medicine, Health Care and Philosophy 18, 103-112, 2015 | 17 | 2015 |
| Results dissemination of registered clinical trials across Polish academic institutions: a cross-sectional analysis K Strzebonska, MT Wasylewski, L Zaborowska, N Riedel, S Wieschowski, ... BMJ Open, 2020 | 12 | 2020 |
| Failures in clinical trials in the European Union: Lessons from the Polish experience M Waligora Science and engineering ethics 19, 1087-1098, 2013 | 9 | 2013 |
| Participant protection in phase 1 pediatric cancer trials J Kimmelman, M Waligora, HF Lynch JAMA pediatrics 173 (1), 8-9, 2019 | 8 | 2019 |
| Is a requirement of personalised assent realistic? A case from the GABRIEL project M Waligora European Journal of Human Genetics, 2013 | 8 | 2013 |
| Child’s objection to non-beneficial research: capacity and distress based models M Waligora, J Różyńska, J Piasecki Medicine, Health Care and Philosophy 19, 65-70, 2016 | 7 | 2016 |
| A European consistency for functioning of RECs? We just lost our chance M Waligora Journal of Medical Ethics 39 (6), 408-409, 2013 | 7 | 2013 |
| Neither the harm principle nor the best interest standard should be applied to pediatric research M Waligora, K Strzebonska, MT Wasylewski The American Journal of Bioethics 18 (8), 72-74, 2018 | 6 | 2018 |
Jan PiaseckiJagiellonian University Medical CollegeE-mail megerősítve itt: uj.edu.pl
